184 Grants (Page 1 of 8)
2021
Basic Sciences Studies on Gene Therapy of Blood Diseases
Broxmeyer, Hal E and Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5T32HL007910-22), $87,201USD, 1999-07-01 -- 2025-06-30
 
Controlling Influences of Oxygen Tension and CD26/DPP4 Enzymatic Activity on Regulation of Hematopoietic Stem/Progenitor Cells and Hematopoiesis During Health, Ageing, and Disease
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R35HL139599-04), $768,104USD, 2018-05-01 -- 2025-04-30
 
Hematopoiesis and Hematological Malignancies Program
Broxmeyer, Hal E
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P30CA082709-22-5168), $32,123USD, 1999-09-22 -- 2024-08-31
 
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
Broxmeyer, Hal E and Srour, Edward F
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 2U54DK106846-06A1), $772,128USD, 2015-08-01 -- 2026-07-31
2020
Basic Sciences Studies on Gene Therapy of Blood Diseases
Broxmeyer, Hal E and Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2T32HL007910-21A1), $331,293USD, 1999-07-01 -- 2025-06-30
 
Controlling Influences of Oxygen Tension and CD26/DPP4 Enzymatic Activity on Regulation of Hematopoietic Stem/Progenitor Cells and Hematopoiesis During Health, Ageing, and Disease
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R35HL139599-03), $768,104USD, 2018-05-01 -- 2025-04-30
 
Hematopoiesis and Hematological Malignancies Program
Broxmeyer, Hal E
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P30CA082709-21-5168), $32,123USD, 1999-09-22 -- 2024-08-31
 
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
Broxmeyer, Hal E and Srour, Edward F
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 3U54DK106846-05S2), $239,533USD, 2015-08-01 -- 2020-07-31
 
Regulation of Hematopoietic Cell Production
Broxmeyer, Hal E and Pelus, Louis M
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5T32DK007519-35), $1USD, 1985-07-01 -- 2021-06-30
2019
Basic Sciences Studies on Gene Therapy of Blood Diseases
Broxmeyer, Hal E and Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5T32HL007910-20), $193,350USD, 07/01/1999 -- 11/30/2019
 
Controlling Influences of Oxygen Tension and CD26/DPP4 Enzymatic Activity on Regulation of Hematopoietic Stem/Progenitor Cells and Hematopoiesis During Health, Ageing, and Disease
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R35HL139599-02), $768,104USD, 05/01/2018 -- 04/30/2025
 
DEK Regulation of Hematopoietic Stem Cell Renewal, Fate, and Hematopoiesis
Broxmeyer, Hal E and Markovitz, David M
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5R01DK109188-04), $499,587USD, 07/01/2016 -- 05/31/2020
 
Hematopoiesis and Hematological Malignancies Program
Broxmeyer, Hal E
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2P30CA082709-20-5168), $32,123USD, 2019
 
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
Broxmeyer, Hal E and Srour, Edward F
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 3U54DK106846-05S1), $19,654USD, 08/01/2015 -- 07/31/2020
 
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
Broxmeyer, Hal E and Srour, Edward F
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5U54DK106846-05), $919,529USD, 08/01/2015 -- 07/31/2020
 
Regulation of Hematopoietic Cell Production
Broxmeyer, Hal E and Pelus, Louis M
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5T32DK007519-34), $61,596USD, 07/01/1985 -- 06/30/2021
2018
Basic Sciences Studies on Gene Therapy of Blood Diseases
Broxmeyer, Hal E and Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5T32HL007910-19), $367,696USD, 07/01/1999 -- 11/30/2019
 
Controlling Influences of Oxygen Tension and CD26/DPP4 Enzymatic Activity on Regulation of Hematopoietic Stem/Progenitor Cells and Hematopoiesis During Health, Ageing, and Disease
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R35HL139599-01), $768,104USD, 05/01/2018 -- 04/30/2025
 
DEK Regulation of Hematopoietic Stem Cell Renewal, Fate, and Hematopoiesis
Broxmeyer, Hal E and Markovitz, David M
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5R01DK109188-03), $499,043USD, 07/01/2016 -- 05/31/2020
 
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
Broxmeyer, Hal E and Srour, Edward F
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5U54DK106846-04), $959,147USD, 08/01/2015 -- 07/31/2020
 
Regulation of Hematopoietic Cell Production
Broxmeyer, Hal E and Pelus, Louis M
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5T32DK007519-33), $292,828USD, 07/01/1985 -- 06/30/2021
2017
Basic Sciences Studies on Gene Therapy of Blood Diseases
Broxmeyer, Hal E and Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5T32HL007910-18), $430,810USD, 07/01/1999 -- 11/30/2019
 
Basic Sciences Studies on Gene Therapy of Blood Diseases
Broxmeyer, Hal E and Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 3T32HL007910-18S1), $3,498USD, 07/01/1999 -- 11/30/2019
 
DEK Regulation of Hematopoietic Stem Cell Renewal, Fate, and Hematopoiesis
Broxmeyer, Hal E and Markovitz, David M
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5R01DK109188-02), $449,087USD, 07/01/2016 -- 05/31/2020
 
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
Broxmeyer, Hal E and Srour, Edward F
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 3U54DK106846-03S1), $10,600USD, 08/01/2015 -- 07/31/2020